SCHEMBL5519397

SCHEMBL5519397

ClCc1nc(-c2cccnc2)c(Br)s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 10/20 0.41
CYP3A4 P08684 4/20 0.41
ALDH1A1 P00352 3/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2E1 P05181 4/20 0.40
CYP2C9 P11712 4/20 0.40
CYP2B6 P20813 4/20 0.40
KDM4E B2RXH2 2/20 0.40
MAPT P10636 2/20 0.40
POLB P06746 1/20 0.40
NQO2 P16083 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA2B P29275 1/20 0.39
CYP2D6 P10635 3/20 0.39
CYP2C19 P33261 3/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
CYP19A1 P11511 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5516349 0.85 CYP2A6 (0.49) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL31469332 0.76 CYP2A6 (0.49) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL13910994 0.68 CYP2A6 (0.70) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL14141735 0.67 RAB9A (0.51) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL15885104 0.66 CYP2A6 (0.48) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL6546123 0.66 MAPK14 (0.58) ADORA2A
SCHEMBL3930250 0.65 CYP2A6 (0.54) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL31284734 0.65 CYP2A6 (0.51) CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E
SCHEMBL1679638 0.64 CYP3A4 (0.58) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL9727832 0.64 CYP2A6 (0.49) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070203155-A1 Compounds And Compositions As Ppar Modulators IRM LLC (BM) 2007-08-30 US disclosed
US-20070203155-A1 Compounds And Compositions As Ppar Modulators IRM LLC (BM) 2007-08-30 US disclosed
CN-1980906-A Compounds and compositions as PPAR modulators IRM LLC (BM) 2007-06-13 CN disclosed
EP-1748993-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2007-02-07 EP disclosed
WO-2005116000-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2005-12-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203155-A1 Compounds And Compositions As Ppar Modulators PPARG, PPARA, PPARD CYP2A6 533/4885CYP3A4 1203/4885ALDH1A1 1651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.